North America

MedPAC has argued for Medicare drug pricing reforms for several years, and federal agencies often take their recommendations seriously. But industry opposition has been the primary roadblock to several MedPAC proposals.

Care for the 15 most prevalent types of cancer in the U.S. cost approximately $156.2 billion in 2018, according to a team researchers.

Some research advocates fear the Advanced Research Projects Agency for Health could be left behind in a crush of end-of-session business and lose momentum.

The drug, avacopan, which will be available under brand name Tavneos in the next few weeks, will have a wholesale price of between $150,000 and $200,000 per patient per year.

The lawsuits are part of the broader multidistrict litigation over Zantac and ranitidine after various drugmakers including the defendants launched recalls of their products in 2019.

In fact, the proposed drug price negotiation program does not authorize the federal government to decide which medications people on Medicare can and cannot get and does not establish or require a particular prescription drug formulary.

A notion in the policy community is that competition between biologics and their biosimilars does not save patients and taxpayers as much as well-functioning generic competition.

In his latest press conference, he implied their policies are linked to donations from big pharmaceutical firms.

The New Jersey Democrat refuses to say whether his resistance to Medicare drug bargaining will turn him against the reconciliation bill.

Medicare and a host of other federal agencies are prohibited by law from accessing this kind of purchasing power.

"Another example of Big Pharma reaping billions from public investment into research".

A U.S. federal court judge dismissed a lawsuit in which the drug maker claimed a would-be rival hired one of its employees, who then allegedly transferred a boatload of confidential information about its best-selling Humira treatment.

OTBB head Sarah Yim says FDA internal thinking is not aligned on the idea and that a lot of convincing was necessary to drop the clinical study requirement for insulin biosimilars.

Vancouver City Council has voted to support a federal application that would allow a "compassion club" model and provide tested drugs in the city.

America is the cradle of breakthrough pharmaceutical innovation. U.S. biopharmaceutical companies create nearly two in every three new medicines.